ICUI
ICU Medical Inc
159.40$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 80.8% | 80.6% | 80.8% | 57.8% | 58.5% | 52.1% | 51.8% | 54.8% | 27.4% | 27.9% | 34.3% | 29.1% | |
| 51.0% | 53.6% | 63.2% | 19.4% | 21.7% | 15.9% | 22.5% | 29.4% | 4.6% | 5.8% | 7.3% | 7.6% | |
| 64.1% | 60.2% | 63.2% | 20.0% | 24.1% | 17.3% | 23.3% | 30.2% | 4.7% | 5.8% | 7.3% | 7.6% | |
| 7.2% | 9.2% | 8.4% | 10.0% | 12.4% | 11.9% | 7.2% | 6.6% | 5.5% | 4.2% | 4.8% | 4.5% | |
| 6.8% | 7.0% | 7.0% | 19.3% | 19.6% | 20.0% | 17.9% | 15.4% | 15.4% | 16.2% | 13.9% | 15.2% | |
| 15.9% | 11.9% | 12.2% | 26.6% | 27.3% | 26.9% | 26.5% | 24.9% | 15.8% | – | – | – | |
| 0.3% | 1.0% | 0.8% | 0.8% | 0.7% | 1.8% | 1.9% | 2.3% | 32.1% | 33.6% | 34.1% | 37.0% | |
| 1.3% | 3.8% | 3.2% | 9.6% | 8.4% | 12.5% | 11.2% | 10.0% | 21.8% | 19.9% | 17.6% | 15.6% | |
| 6.1% | 7.5% | 6.3% | 20.0% | 20.3% | 18.6% | 14.8% | 14.1% | 53.7% | 51.5% | 53.3% | 47.6% | |
| 5.3% | 6.8% | 5.8% | 14.0% | 15.7% | 14.7% | 11.1% | 10.7% | 11.0% | 11.0% | 13.2% | 12.3% | |
| – | – | – | 0.6% | 0.4% | 0.4% | 0.5% | 0.5% | 1.1% | 1.6% | 1.6% | 0.9% | |
| 2.1% | 2.2% | 2.1% | 5.2% | 7.6% | 7.6% | 4.1% | 4.3% | 4.8% | 3.4% | 3.5% | 3.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 36.0% | 36.0% | 36.4% | 31.3% | |
| 93.9% | 92.5% | 93.7% | 80.0% | 79.7% | 81.4% | 85.2% | 85.9% | 46.3% | 48.5% | 46.7% | 52.4% | |
| 75.6% | 72.4% | 73.4% | 39.1% | 39.2% | 42.6% | 45.8% | 48.5% | 18.5% | 18.5% | 16.4% | 17.1% | |
| 2.9% | 2.6% | 2.4% | 1.4% | 1.4% | 1.3% | 1.2% | 1.2% | 0.5% | 0.6% | 0.6% | 0.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.